Altered expression of TGF-beta receptors in hepatocellular carcinoma--effects of a constitutively active TGF-beta

Annemarie Musch1, Christian Rabe, Mignon-Denise Paik

  • 1Department of Medicine I, University of Bonn, Germany.

Digestion
|March 19, 2005
PubMed
Abstract

Insights

Hepatocellular carcinoma (HCC) resistance to transforming growth factor-beta (TGF-beta) may stem from reduced TGF-beta receptor II (TGF-betaRII) expression. Restoring TGF-beta receptor I (TGF-betaRI) function in HCC cells decreased proliferation without increasing invasiveness.

Area of Science:

  • Hepatocellular carcinoma (HCC) research
  • Molecular mechanisms of cancer resistance
  • TGF-beta signaling pathway

Background:

  • Hepatocellular carcinoma (HCC) frequently exhibits resistance to transforming growth factor-beta (TGF-beta) signaling.
  • Understanding the molecular basis of this resistance is crucial for developing effective therapies.

Purpose of the Study:

  • To investigate the molecular mechanisms underlying TGF-beta resistance in HCC.
  • To explore strategies for overcoming TGF-beta resistance in HCC.

Main Methods:

  • Analyzing TGF-beta type I and type II receptor (TGF-betaRI/RII) expression in clinical HCCs and hepatoma cell lines (HuH-7, HepG2).
  • Transfecting HuH-7 cells with a constitutively active TGF-betaRI mutant (CA TGF-betaRI).
  • Assessing growth kinetics, integrin expression, invasiveness, PAI-1 promoter activation, and Smad expression in transfected cells.

Main Results:

  • Clinical HCCs showed altered TGF-betaRI/RII protein expression compared to adjacent liver tissue.
  • HuH-7 cells with decreased TGF-betaRII expression exhibited resistance.
  • Stable transfection with CA TGF-betaRI in HuH-7 cells attenuated PAI-1 promoter response, increased Smad7 expression, and decreased proliferation without affecting invasiveness.

Conclusions:

  • Reduced TGF-betaRII protein expression may contribute to TGF-beta resistance in a subset of HCC.
  • Stable expression of CA TGF-betaRI can reverse TGF-beta resistance in HCC cells, offering a potential therapeutic avenue without enhancing invasiveness.

Related Concept Videos

TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
Cirrhosis II: Pathophysiology01:24

Cirrhosis II: Pathophysiology

Cirrhosis is a progressive chronic liver injury caused by prolonged inflammation, excessive fibrotic remodeling, and impaired regeneration. Over time, repeated hepatic insults disrupt the liver’s architecture and function, leading to reduced blood flow, impaired bile drainage, and diminished metabolic capacity.Pathophysiology of cirrhosisCirrhosis arises from three main responses to chronic liver damage: inflammation, immune activation, and hepatocyte death. These processes lead to structural...
Liver Regeneration01:24

Liver Regeneration

The liver is an important organ in vertebrates that plays an essential role in metabolism. It is also responsible for storing and redistributing nutrients such as carbohydrates, fats, and vitamins in the body. Additionally, the liver releases bile salts which are critical for digesting food and eliminating toxic metabolites from the body.
Cells of Liver
The liver comprises four major types of cells— hepatocytes, stellate, Kupffer, and sinusoidal endothelial cells. The hepatocytes are large...